IndraLab
Statements
rlimsp
"Interestingly, the hypophosphorylated form of NPM (3A) augmented this expression even further. Consistently, this NPM mutant could highly activate the E2F1 promoter activity, as shown by a reporter assay (Figure 4B). In contrast, expression of the phosphomimetic variant (3D) did not result in any significant alteration of the E2F1 mRNA level (Figure 4A). Another phosphodefective mutant that was altered on one of the MS-identified phosphorylation sites (S125A) also did not further activate E2F1 promoter activity compared with wild-type NPM (Supplemental Figure S4C), suggesting a lack of involvement of this residue in this functional aspect."